H
Loading...
Loading...
CDC PLACES (2023, crude) estimates 14.6% of adults in Kansas City have diagnosed diabetes — 2.6 points above the U.S. 12% figure. Census population 156,607. Kansas Medicare wound biologics: WPS Government Health Administrators (J5). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Kansas City clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Kansas City storefront.
Growth Factor Therapy for Tissue Repair in Kansas City, KS for clinics & physicians. Growth factor therapy… Compliance support & pricing — contact Hawk Medical.
Adult arthritis here is 23.3% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. CDC PLACES (2023, crude) estimates 14.6% of adults in Kansas City have diagnosed diabetes — 2.6 points above the U.S. 12% figure. Together those PLACES numbers are why a city under 250k still needs separate PRP and CTP protocols. growth factor therapy inventory is national; utilization is J5-local.
National Growth Factor Therapy for Tissue Repair notes (how the product actually works)America’s Health Rankings (BRFSS 2024) only publishes state diabetes as a range nationally (Colorado 8.4% to West Virginia 18.4%). For Kansas City we use CDC PLACES instead of interpolating a fake city rate from that range. CDC PLACES (2023, crude) estimates 14.6% of adults in Kansas City have diagnosed diabetes — 2.6 points above the U.S. 12% figure.
We are not going to invent a Kansas City warehouse or a five-star local review. What you get is growth factor therapy from FDA-registered sources, lot paperwork, and someone who has run the same SOPs in clinic — Joe Bradley. The local numbers on this page are CDC PLACES and CMS J5, not marketing adjectives.
CDC PLACES (2023, crude prevalence) estimates 14.6% of adults — 2.6 points above the U.S. 12% figure. Obesity is 41.2%; arthritis is 23.3%. That is place-level BRFSS modeling, not a clinic census and not a Kansas City trial.
No. Hawk Medical LLC is a national distributor founded in 2014. We ship HCT/P 361-compliant tissue, PRP systems, and wound-care biologics to physician practices nationwide, including Kansas. There is no Kansas City storefront or local street address on this page because we are a service-area distributor, not a walk-in clinic.
City-proper counts are unambiguous and match the URL slug. MSA figures change with OMB delineations and would be easy to get wrong. We would rather under-claim than invent a metro number.
It is the Census city-proper count — useful as scale for a city under 250k. It is not a count of orthopedic groups, wound centers, or competitors. Underwrite the program against your referral sources, not against the skyline.
If you operate in Kansas and another MAC state, say it on the first call. J5 will not port 1:1. We would rather split utilization than watch a sister clinic copy Kansas City tickets into the wrong jurisdiction.
Contact us to learn how Hawk Medical supports practices in Kansas City, KS.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Kansas City is J5 geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Kansas City — 2.6 points above the U.S. 12% figure. Planning input, not an outcomes claim.
Kansas Part B wound biologics follow this contractor (siblings: IA, MO, NE). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Kansas City. Useful for joint-program math; still needs a diagnosis and privileging.
No Kansas City storefront. Joe Bradley is an active practice owner. growth factor therapy stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.